Financials
March 13, 2018 / 6:05 PM / a year ago

BRIEF-Crinetics Pharma Completes $63.5 Mln Series B Financing

1 Min Read

March 13 (Reuters) - Crinetics Pharmaceuticals:

* CRINETICS PHARMACEUTICALS COMPLETES $63.5 MILLION SERIES B FINANCING

* CRINETICS PHARMA, A RARE DISEASE THERAPEUTICS CO, SAYS INVESTMENT LED BY PERCEPTIVE ADVISORS & INCLUDES NEW INVESTORS RA CAPITAL & ORBIMED Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below